Project title: A PHARMACEUTICAL TO COMBAT SKIN ATROPHY

Company name : TOPIMED LTD.

TECHNOLOGICAL FIELD
Pharmaceuticals

KEY WORDS
Medicinal, Cosmetical

PROJECT SUMMARY
A patented therapeutic approach to combat skin atrophy for
medicinal as well as cosmetic purposes. The preparation will
contain an agent that reverses the thinning of the epithelial
parameters and reverses the loss of hyaluronate in the dermis of
postmenopausal women. Tests carried out on human volunteers
indicated acceptable levels of safety for cosmetic use.

ADVANTAGES
* The product is a pharmaceutical, not a cosmeceutical.
* Able to structurally alter the skin.
* Active agent.
* Does not sensitize the skin to sunlight or UV radiation.

APPLICATIONS
AND TARGET MARKETS
The product will be marketed for three applications: for the
treatment of skin atrophy, photo-aged skin and for the cosmetic
treatment of wrinkles. The product enters a market that presently
has a huge demand, but no real solution. The market size for
anti-wrinkle and skin rejuvenation in the USA is estimated at
US$2B per annum.

ENTREPRENEURS
Prof. Shabtay Dikstein - D.Sc., an expert
in the fields of dermopharmacology and inflammation control
through dermopharmacology.

PROJECT STATUS
Clinical trials are being performed in cooperation with
Tel-Hashomer Hospital.

COOPERATION REQUIRED
Strategic partners and investors.
---------------------------------------------
TEL: 972-8-6751122; FAX: 972-8-6751113 E-MAIL: ati@ati.co.il

Request for more information, about this project.

Note - you have to be registered in this server to request information. If you haven't done so yet, please:
Register in this server and your requests will be forwarded to the developer, who will contact you directly

List of projects that you already requested more information about